2024 HCPCS Code J2779
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
TAGS: implant intravitreal
| Short Description | Inj, susvimo 0.1 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | July 01, 2022 |
| HCPCS Code Added Date | July 01, 2022 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J7639 - Dornase alfa non-comp unit
- J7640 - Formoterol comp unit
- J7641 - Flunisolide comp unit
- J7642 - Glycopyrrolate comp con
- J7643 - Glycopyrrolate comp unit
- J7644 - Ipratropium bromide non-comp
- J7645 - Ipratropium bromide comp
- J7647 - Isoetharine comp con
- J7648 - Isoetharine non-comp con
- J7649 - Isoetharine non-comp unit
- J7650 - Isoetharine comp unit
- J7657 - Isoproterenol comp con
- J7658 - Isoproterenol non-comp con
- J7659 - Isoproterenol non-comp unit
- J7660 - Isoproterenol comp unit
- J7665 - Mannitol for inhaler
- J7667 - Metaproterenol comp con
- J7668 - Metaproterenol non-comp con
- J7669 - Metaproterenol non-comp unit
- J7670 - Metaproterenol comp unit